Vaccines Archive — Page 13 of 14

March 7, 2016

Vanderbilt researchers identify potential antibody treatment for H7 avian flu

Researchers at Vanderbilt University Medical Center have isolated human antibodies against a type of bird flu that has killed more than 200 people in China since 2012 and which may pose a worldwide pandemic threat.

By Bill Snyder
February 4, 2016

VICC joins other major cancer centers in HPV vaccine campaign

In response to low national vaccination rates for the human papillomavirus (HPV), Vanderbilt-Ingram Cancer Center (VICC) has joined 68 of the nation’s other NCI-designated cancer centers in recommending increased HPV vaccination for the prevention of cancer.

By Vanderbilt Health News
January 21, 2016

Antibodies may be ‘silver bullet’ for Ebola viruses

There may be a “silver bullet” for Ebola, a family of hemorrhagic viruses, one of which has killed more than 11,000 people in West Africa in the past two years.

By Bill Snyder
October 8, 2015

Creech to direct Vanderbilt Vaccine Research Program

Buddy Creech, M.D., MPH, associate professor of Pediatrics, has been named director of the Vanderbilt Vaccine Research Program (VVRP) in the Division of Pediatric Infectious Diseases.

By Vanderbilt Health News
flu shot
October 6, 2015

Flu vaccine helps reduce hospitalizations due to influenza pneumonia: study

More than half of hospitalizations due to influenza pneumonia could be prevented by influenza vaccination, according to a study led by investigators at Vanderbilt University Medical Center, published this week in the Journal of the American Medical Association.

By Paul Govern
July 9, 2015

Study could lead to vaccine for mosquito-borne dengue virus

Researchers at Vanderbilt University and the National University of Singapore have determined the structure of a human monoclonal antibody which, in an animal model, strongly neutralizes a type of the potentially lethal dengue virus.

By Bill Snyder